This topic contains a solution. Click here to go to the answer

Author Question: All of the following statements are true about transfusion-related immunomodulation (TRIM) except ... (Read 57 times)

jjjetplane

  • Hero Member
  • *****
  • Posts: 556
All of the following statements are true about transfusion-related immunomodulation (TRIM) except
 
  a. Cause remains unproven.
  b. First recognized in liver transplant recipients.
  c. Possible deleterious effects include increased recurrence of cancer.
  d. Refers to immune suppression following transfusion of allogeneic blood products.

Question 2

In the United States, transfusion-associated fatalities must be reported to which regulatory agency?
 
  a. American Medical Association
  b. Centre for Biologics Evaluation and Research
  c. Food and Drug Administration
  d. Haemovigilance network



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mariahkathleeen

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

Answer: b

Answer to Question 2

Answer: b




jjjetplane

  • Member
  • Posts: 556
Reply 2 on: Jun 25, 2018
Wow, this really help


nanny

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library